Catalyst Wire Dossier Catalyst Wire Dossier

JNJ-42847922

· Janssen Research & Development, LLC
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for JNJ-42847922, covering 2016-02-04 to 2025-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants [Phase 1]

See pricing